Adial Pharmaceuticals (ADIL) Institutional Ownership → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ADIL Stock Alerts $1.70 -0.20 (-10.53%) (As of 04/23/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Adial Pharmaceuticals (NASDAQ:ADIL)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$10.82MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$3.21M Get ADIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADIL Institutional Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Adial Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC159,000$296K0.0%N/A9.578% 11/9/2023Manchester Capital Management LLC48,097$134K0.0%-96.0%3.942% 5/9/2023Manchester Capital Management LLC1,202,452$421K0.1%N/A4.216% 11/7/2022Virtu Financial LLC77,694$27K0.0%+142.7%0.301% 8/2/2022Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088% 7/22/2022Truist Financial Corp33,862$45K0.0%N/A0.142% Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/13/2022Private Advisor Group LLC21,400$29K0.0%-37.3%0.090% 11/12/2021Oppenheimer & Co. Inc.38,500$165K0.0%+37.5%0.190% 11/12/2021NorthRock Partners LLC10,000$43K0.0%N/A0.049% 10/29/2021Commonwealth Equity Services LLC36,461$156K0.0%+25.5%0.180% 9/17/2021Virtu Financial LLC31,038$79K0.0%N/A0.153% 8/16/2021State Street Corp48,954$125K0.0%N/A0.260% 8/13/2021Northern Trust Corp21,873$56K0.0%N/A0.116% 8/13/2021Geode Capital Management LLC88,246$225K0.0%+13.2%0.469% 8/13/2021Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112% 8/11/2021Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155% 8/3/2021Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152% 7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134% 5/14/2021Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179% 5/13/2021Barclays PLC15,850$38K0.0%N/A0.091% 5/12/2021Rede Wealth LLC15,000$36K0.0%N/A0.086% 5/10/2021Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083% 5/4/2021Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126% 4/22/2021Private Advisor Group LLC36,650$89K0.0%N/A0.212% 3/8/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% 2/25/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% 2/10/2021Renaissance Technologies LLC98,900$168K0.0%+6.5%0.687% 12/11/2020Virtu Financial LLC18,902$42K0.0%N/A0.131% 8/14/2020Bank of America Corp DE150,000$209K0.0%N/A1.115% (Data available from 1/1/2016 forward) ADIL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADIL shares? During the previous two years, the following institutional investors and hedge funds held shares of Adial Pharmaceuticals shares: Armistice Capital LLC ($296K), Manchester Capital Management LLC ($134K), Truist Financial Corp ($45K), Private Advisor Group LLC ($29K), and Thompson Davis & CO. Inc. ($28K), Virtu Financial LLC ($27K).Learn more on ADIL's institutional investors. What percentage of Adial Pharmaceuticals stock is owned by institutional investors? 16.41% of Adial Pharmaceuticals stock is owned by institutional investors. Learn more on ADIL's institutional investor holdings. Which institutional investors have been buying Adial Pharmaceuticals stock? The following institutional investors have purchased Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.20M), Armistice Capital LLC ($159K), Virtu Financial LLC ($45.68K), Truist Financial Corp ($33.86K), and Thompson Davis & CO. Inc. ($21K). How much institutional buying is happening at Adial Pharmaceuticals? Institutional investors have bought a total of 1,461,995 shares in the last 24 months. This purchase volume represents approximately $13.05M in transactions. Which Adial Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.15M), and Private Advisor Group LLC ($12.75K). How much institutional selling is happening at Adial Pharmaceuticals? Institutional investors have sold a total of 1,167,105 shares in the last 24 months. This volume of shares sold represents approximately $3.64M in transactions. Related Companies: Akari Therapeutics Major Shareholders Biofrontera Major Shareholders Molecular Templates Major Shareholders Galera Therapeutics Major Shareholders Longeveron Major Shareholders Hepion Pharmaceuticals Major Shareholders Virios Therapeutics Major Shareholders Alterity Therapeutics Major Shareholders Cyclerion Therapeutics Major Shareholders Moleculin Biotech Major Shareholders This page (NASDAQ:ADIL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.